FDA Announces Myocarditis Risk for mRNA Vaccines

The FDA has announced a risk of myocarditis, an inflammation of the heart muscle, linked to mRNA vaccines, such as those widely used to combat COVID-19. This announcement from the U.S. regulatory body, responsible for ensuring medical product safety, is based on data from clinical trials and post-marketing surveillance.

Subscribe To Newsletter
https://LawfareCo.Substack.com

Access Uncensored Content
https://Mitha.Locals.com/support

Book Consultations
https://Lawfare.co/Mitha

Connect with Mitha
X: https://www.twitter.com/MithaEXP
Instagram: https://www.instagram.com/MithaEXP
YouTube: https://youtube.com/@MithaEXP
Spotify: https://creators.spotify.com/pod/show/MithaUS